Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...

The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...

A couple facing a terminal multiple myeloma diagnosis finds renewed hope through innovative immunotherapy, transforming blood ...

From uncertainty to hope for the future, they offer advice on getting through some of the toughest years of their lives ...

In a Community Case Forum in partnership with the North Carolina Oncology Association, Cristina Gasparetto, MD, discussed the ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

Films like Strong: Living with Multiple Myeloma are essential. Multiple Myeloma is not exactly high on the list of diseases ...

“The trial results support D-VRd becoming the new standard of care for patients with newly diagnosed transplant ineligible or transplant-deferred multiple myeloma.” Transplant-Ineligible and ...

Philadelphia Eagles stars carried away by their stunning Super Bowl victory prompted several apologies from American news anchors during their championship parade on Sunday. The Eagles thrashed ...

A relapse of multiple myeloma is difficult to treat. Myeloma cells that have survived after undergoing rounds and rounds of various treatments to cause relapse typically are the most resistant of the ...